vs

Side-by-side financial comparison of Arteris, Inc. (AIP) and ENANTA PHARMACEUTICALS INC (ENTA). Click either name above to swap in a different company.

Arteris, Inc. is the larger business by last-quarter revenue ($20.1M vs $18.6M, roughly 1.1× ENANTA PHARMACEUTICALS INC). Arteris, Inc. runs the higher net margin — -42.2% vs -64.1%, a 21.9% gap on every dollar of revenue. On growth, Arteris, Inc. posted the faster year-over-year revenue change (30.0% vs 9.8%). Arteris, Inc. produced more free cash flow last quarter ($3.0M vs $-11.8M). Over the past eight quarters, Arteris, Inc.'s revenue compounded faster (24.7% CAGR vs 4.5%).

Arteris, Inc. is a multinational technology company headquartered in Campbell, California. It develops the network-on-chip (NoC) IP and system-on-chip (SoC) integration automation software that is used to create semiconductor chip and chiplet designs for a variety of devices, particularly in automotive electronics, artificial intelligence, machine learning, enterprise computing, communications, consumer, industrial, and aerospace & defense markets. The company specializes in the development a...

Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.

AIP vs ENTA — Head-to-Head

Bigger by revenue
AIP
AIP
1.1× larger
AIP
$20.1M
$18.6M
ENTA
Growing faster (revenue YoY)
AIP
AIP
+20.2% gap
AIP
30.0%
9.8%
ENTA
Higher net margin
AIP
AIP
21.9% more per $
AIP
-42.2%
-64.1%
ENTA
More free cash flow
AIP
AIP
$14.9M more FCF
AIP
$3.0M
$-11.8M
ENTA
Faster 2-yr revenue CAGR
AIP
AIP
Annualised
AIP
24.7%
4.5%
ENTA

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AIP
AIP
ENTA
ENTA
Revenue
$20.1M
$18.6M
Net Profit
$-8.5M
$-11.9M
Gross Margin
90.8%
Operating Margin
-42.0%
-60.5%
Net Margin
-42.2%
-64.1%
Revenue YoY
30.0%
9.8%
Net Profit YoY
-3.7%
46.4%
EPS (diluted)
$-0.19
$-0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIP
AIP
ENTA
ENTA
Q4 25
$20.1M
$18.6M
Q3 25
$17.4M
$15.1M
Q2 25
$16.5M
$18.3M
Q1 25
$16.5M
$14.9M
Q4 24
$15.5M
$17.0M
Q3 24
$14.7M
$14.6M
Q2 24
$14.6M
$18.0M
Q1 24
$12.9M
$17.1M
Net Profit
AIP
AIP
ENTA
ENTA
Q4 25
$-8.5M
$-11.9M
Q3 25
$-9.0M
$-18.7M
Q2 25
$-9.1M
$-18.3M
Q1 25
$-8.1M
$-22.6M
Q4 24
$-8.2M
$-22.3M
Q3 24
$-7.7M
$-28.8M
Q2 24
$-8.3M
$-22.7M
Q1 24
$-9.4M
$-31.2M
Gross Margin
AIP
AIP
ENTA
ENTA
Q4 25
90.8%
Q3 25
89.9%
Q2 25
89.4%
Q1 25
90.8%
Q4 24
89.8%
Q3 24
90.1%
Q2 24
90.0%
Q1 24
88.7%
Operating Margin
AIP
AIP
ENTA
ENTA
Q4 25
-42.0%
-60.5%
Q3 25
-50.1%
-121.6%
Q2 25
-50.0%
-103.2%
Q1 25
-46.6%
-164.3%
Q4 24
-45.9%
-138.8%
Q3 24
-53.8%
-204.4%
Q2 24
-51.1%
-134.6%
Q1 24
-70.5%
-192.1%
Net Margin
AIP
AIP
ENTA
ENTA
Q4 25
-42.2%
-64.1%
Q3 25
-51.6%
-123.6%
Q2 25
-55.3%
-99.7%
Q1 25
-49.1%
-151.7%
Q4 24
-53.0%
-131.4%
Q3 24
-52.2%
-197.3%
Q2 24
-57.2%
-126.1%
Q1 24
-72.6%
-182.7%
EPS (diluted)
AIP
AIP
ENTA
ENTA
Q4 25
$-0.19
$-0.42
Q3 25
$-0.21
$-0.88
Q2 25
$-0.22
$-0.85
Q1 25
$-0.20
$-1.06
Q4 24
$-0.19
$-1.05
Q3 24
$-0.20
$-1.36
Q2 24
$-0.22
$-1.07
Q1 24
$-0.25
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIP
AIP
ENTA
ENTA
Cash + ST InvestmentsLiquidity on hand
$33.9M
$37.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$-14.6M
$126.6M
Total Assets
$115.0M
$329.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIP
AIP
ENTA
ENTA
Q4 25
$33.9M
$37.4M
Q3 25
$39.0M
$32.3M
Q2 25
$38.0M
$44.8M
Q1 25
$42.3M
$60.2M
Q4 24
$43.8M
$84.3M
Q3 24
$48.7M
$37.2M
Q2 24
$45.8M
$35.8M
Q1 24
$44.8M
$63.5M
Stockholders' Equity
AIP
AIP
ENTA
ENTA
Q4 25
$-14.6M
$126.6M
Q3 25
$-11.4M
$64.7M
Q2 25
$-7.5M
$79.3M
Q1 25
$-4.8M
$93.5M
Q4 24
$-1.2M
$111.8M
Q3 24
$2.2M
$128.8M
Q2 24
$5.3M
$148.9M
Q1 24
$9.5M
$166.1M
Total Assets
AIP
AIP
ENTA
ENTA
Q4 25
$115.0M
$329.5M
Q3 25
$107.7M
$280.7M
Q2 25
$106.9M
$301.0M
Q1 25
$98.3M
$323.0M
Q4 24
$106.1M
$348.6M
Q3 24
$97.7M
$376.7M
Q2 24
$96.4M
$398.8M
Q1 24
$101.4M
$413.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIP
AIP
ENTA
ENTA
Operating Cash FlowLast quarter
$3.2M
$-11.7M
Free Cash FlowOCF − Capex
$3.0M
$-11.8M
FCF MarginFCF / Revenue
15.1%
-63.6%
Capex IntensityCapex / Revenue
0.7%
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.3M
$-18.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIP
AIP
ENTA
ENTA
Q4 25
$3.2M
$-11.7M
Q3 25
$3.2M
$-6.5M
Q2 25
$-2.5M
$17.5M
Q1 25
$2.9M
$-13.5M
Q4 24
$-2.6M
$-16.8M
Q3 24
$1.1M
$-10.4M
Q2 24
$311.0K
$-14.8M
Q1 24
$477.0K
$-28.6M
Free Cash Flow
AIP
AIP
ENTA
ENTA
Q4 25
$3.0M
$-11.8M
Q3 25
$2.5M
$-7.9M
Q2 25
$-2.8M
$17.4M
Q1 25
$2.7M
$-16.0M
Q4 24
$-2.7M
$-25.5M
Q3 24
$1.1M
$-19.4M
Q2 24
$264.0K
$-21.3M
Q1 24
$281.0K
$-30.3M
FCF Margin
AIP
AIP
ENTA
ENTA
Q4 25
15.1%
-63.6%
Q3 25
14.2%
-52.5%
Q2 25
-17.2%
94.7%
Q1 25
16.2%
-107.4%
Q4 24
-17.3%
-150.6%
Q3 24
7.4%
-132.5%
Q2 24
1.8%
-118.6%
Q1 24
2.2%
-177.5%
Capex Intensity
AIP
AIP
ENTA
ENTA
Q4 25
0.7%
0.8%
Q3 25
4.1%
9.6%
Q2 25
2.2%
0.8%
Q1 25
1.1%
17.0%
Q4 24
0.3%
51.6%
Q3 24
0.2%
61.3%
Q2 24
0.3%
36.4%
Q1 24
1.5%
9.8%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AIP
AIP

License And Maintenance$17.5M87%
Variable Royalties And Other$2.6M13%

ENTA
ENTA

Segment breakdown not available.

Related Comparisons